Cytokinetics Stock Story

CYTK
 Stock
  

USD 46.99  2.85  6.46%   

Cytokinetics investor sentiment overview provides quick insight into current market opportunities from investing in Cytokinetics. The current market sentiment together Cytokinetics' historical and current headlines can help investors to time the market. Many technical investors use Cytokinetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Cytokinetics Hype Analysis, Cytokinetics Correlation and Cytokinetics Performance.
  
Refresh
Cytokinetics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Cytokinetics daily returns and investor perception about the current pice of Cytokinetics as well as its diversification or hedging effects on your existing portfolios.

Cytokinetics Latest Sentiment Indicators

200 Day MA
37.91
Short Percent
0.14
Short Ratio
11.8
Shares Short Prior Month
8.7 M
50 Day MA
40.29
52 Week Low
17.72
Shares Short
8.5 M

Cytokinetics Current Investor Sentiment

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Cytokinetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cytokinetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cytokinetics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Cytokinetics.

Cytokinetics Maximum Pain Price across 2022-07-15 Option Contracts

Cytokinetics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Cytokinetics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Cytokinetics' options.
Exercise or conversion by Fady Malik of 13987 shares of Cytokinetics subject to Rule 16b-3
Filed transaction by Cytokinetics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Cytokinetics insider trading alert for exercise of incentive stock option (right to buy) by Fady Malik, EVP Research & Development, on 12th of May 2022. This event was filed by Cytokinetics Inc with SEC on 2022-05-12. Statement of changes in beneficial ownership - SEC Form 4. Fady Malik currently serves as senior vice president - research and early development of Cytokinetics

Cash Flow Correlation

Cytokinetics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cytokinetics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Cytokinetics Fundamental Analysis

We analyze Cytokinetics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytokinetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytokinetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price to Earnings To Growth

Price to Earnings To Growth Comparative Analysis

PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Peers

Your Trending Equities

TWST  7.05   
0%
100.0%
XOM  3.61   
0%
51.0%
VST  1.89   
0%
26.0%
VLUE  1.37   
0%
19.0%
FRHC  1.10   
0%
15.0%
ARMK  0.92   
0%
13.0%
MHNC  0.41   
0%
5.0%
QYLD  0.28   
0%
4.0%
TAXI  0.00   
0%
0%
HAR  0.00   
0%
0%
SSS  0.00   
0%
0%
HZNSF  0.00   
0%
0%
GDI  0.00   
0%
0%
DPS  0.00   
0%
0%
POW  0.10   
1.0%
0%
FMURX  0.32   
4.0%
0%
MOTO  0.35   
5.0%
0%
VGLT  0.54   
7.0%
0%
BNPQF  0.91   
12.0%
0%
AMN  1.19   
16.0%
0%
Continue to Cytokinetics Hype Analysis, Cytokinetics Correlation and Cytokinetics Performance. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.8 B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.